LifeScience Biologics

Lonza Licenses NeuroPortal Blood-Brain Barrier Technology to China Medical System

Lonza grants CMS global rights to newly acquired TfR1 technology in up to two neurodegenerative disease targets.  Lonza’s NeuroPortal...

 November 18, 2026 | News

Delonix Bioworks and A*STAR IDL Collaborate on Vaccines Against Drug-Resistant Klebsiella pneumoniae

Delonix Bioworks, a clinical-stage biotechnology company pioneering next-generation outer membrane vesicle (OMV) vaccines, today announced that it has ente...

 November 18, 2026 | News

China’s NMPA Accepts Akeso’s Ivonescimab Application for First-Line Biliary Tract Cancer

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accepted the supplemental ...

 November 18, 2026 | News

Eppendorf and Nova Biomedical Integrate Sampling and Analysis to Automate Bioprocess Control

Eppendorf and Nova Biomedical® collaborate to integrate the Eppendorf Bioprocess Autosampler with the BioProfile FLEX2 cell culture analyzer. The integ...

 November 18, 2026 | News

Innovent’s Zybrivo Receives Positive CHMP Opinion for Advanced Lung Cancer

The opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) is Innovent's first European regulatory...

 November 17, 2026 | News

IDEAYA Nominates IDE101 as Development Candidate for CDKN2A-Deficient Solid Tumours

Development candidate demonstrates encouraging preclinical activity in CDKN2A-deficienct tumor models as a monotherapy and in combi...

 November 17, 2026 | News

Eli Radiopharma Raises Nearly RMB 400 Million in Series A to Advance Radiopharmaceutical Pipeline

Hangzhou Eli Radiopharma Co., Ltd. ("Eli Radiopharma", or "the Company"), an innovative radiopharmaceutical company focused on integrated diagnostics and t...

 November 16, 2026 | News

HTL Biotechnology Opens €15 Million Polynucleotide Production Unit in France

HTL Biotechnology, a world leader in the development and production of pharmaceutical-grade biopolymers, inaugurated its new production unit, HTL8, dedicat...

 November 16, 2026 | News

Zai Lab Secures China NRDL Coverage for Five Medicines, Including Two New Listings

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, announced that five of its commercial medicines in China have b...

 November 16, 2026 | News

Biomatter Raises $18 Million to Accelerate AI-Designed Enzymes From Lab to Market

AstraZeneca, BASF, and Sanofi among 25+ enterprise customers, with more than 50 custom enzymes delivered Proceeds will grow the commercial team and US p...

 November 13, 2026 | News

Pfizer Secures Up to $1.5 Billion From Blackstone to Advance Monthly GLP-1 Programme

Blackstone to provide Pfizer up to $1.5 billion through 2028 to support clinical program for GLP-1 receptor agonist Pfizer Inc. (NYSE: PFE) and Blackstone...

 November 13, 2026 | News

Sino Biological Introduces 4RISE to Accelerate Validation of AI-Designed Proteins

Faster Expression. Deeper Validation. Integrated Support. AI can generate protein candidates at an unprecedented speed, but experimental validation remain...

 November 12, 2026 | News

Abbisko’s PIMJETMI Secures FDA Approval for Symptomatic Tenosynovial Giant Cell Tumour

PIMJETMI® (pimicotinib) is a new systemic treatment option for certain U.S. adult patients with symptomatic tenosynovial giant cell tumor (TGCT), dem...

 November 12, 2026 | News

Neobe Therapeutics Raises US$6.8 Million to Advance Engineered Bacteria for Solid Tumours

 Neobe has secured a seed round of US$6.8 million (£5 million) to accelerate the development of engineered bacteria that break down the physical...

 November 11, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close